关注
Andrea Loreto
Andrea Loreto
Private Practice
在 andrealoreto.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
M Di Stefano, I Nascimento-Ferreira, G Orsomando, V Mori, J Gilley, ...
Cell Death & Differentiation 22 (5), 731-742, 2015
2612015
Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca2+ influx but only modestly influenced by mitochondria
A Loreto, M Di Stefano, M Gering, L Conforti
Cell reports 13 (11), 2539-2552, 2015
1452015
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration
A Loreto, CS Hill, VL Hewitt, G Orsomando, C Angeletti, J Gilley, C Lucci, ...
Neurobiology of disease 134, 104678, 2020
1142020
NMN deamidase delays wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo
M Di Stefano, A Loreto, G Orsomando, V Mori, F Zamporlini, RP Hulse, ...
Current Biology 27 (6), 784-794, 2017
1042017
Advances in applying computer-aided drug design for neurodegenerative diseases
MM Salman, Z Al-Obaidi, P Kitchen, A Loreto, RM Bill, R Wade-Martins
International journal of molecular sciences 22 (9), 4688, 2021
972021
Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma
G Simone, R Papalia, A Loreto, C Leonardo, S Sentinelli, M Gallucci
BJU international 103 (8), 1052-1057, 2009
902009
Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss
MA White, Z Lin, E Kim, CM Henstridge, E Pena Altamira, CK Hunt, ...
Acta neuropathologica communications 7, 1-16, 2019
712019
SARM1 is a multi-functional NAD (P) ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites
C Angeletti, A Amici, J Gilley, A Loreto, AG Trapanotto, C Antoniou, ...
Iscience 25 (2), 2022
602022
Structural basis for RING-Cys-Relay E3 ligase activity and its role in axon integrity
PD Mabbitt, A Loreto, MA Déry, AJ Fletcher, M Stanley, KC Pao, NT Wood, ...
Nature chemical biology 16 (11), 1227-1236, 2020
562020
Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia
A Sciarra, G D'Eramo, P Casale, A Loreto, M Buscarini, S Di Nicola, ...
The Prostate 34 (2), 121-128, 1998
521998
Mitochondrial dysfunction as a trigger of programmed axon death
E Merlini, MP Coleman, A Loreto
Trends in Neurosciences 45 (1), 53-63, 2022
432022
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain
HC Feldman, E Merlini, C Guijas, KE DeMeester, E Njomen, EM Kozina, ...
Proceedings of the National Academy of Sciences 119 (35), e2208457119, 2022
422022
Relationship among age, prostate‐specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign …
F Di Silverio, A Sciarra, G D'Eramo, P Casale, A Loreto, F Seccareccia
The Prostate 36 (1), 1-7, 1998
361998
Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1
A Loreto, C Angeletti, W Gu, A Osborne, B Nieuwenhuis, J Gilley, ...
Elife 10, e72823, 2021
352021
Novel HDAC6 inhibitors increase tubulin acetylation and rescue axonal transport of mitochondria in a model of Charcot–Marie–Tooth type 2F
R Adalbert, A Kaieda, C Antoniou, A Loreto, X Yang, J Gilley, T Hoshino, ...
ACS chemical neuroscience 11 (3), 258-267, 2019
292019
NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy
F Rossi, PC Geiszler, W Meng, MR Barron, M Prior, A Herd-Smith, ...
Behavioural brain research 339, 140-152, 2018
242018
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes
G Di Pasquale, I Dicembrini, L Raimondi, C Pagano, JM Egan, A Cozzi, ...
PLoS One 7 (7), e40074, 2012
242012
DIMA Ploidy, Gleason Score, Pathological Stage and Serum PSA Levels as Predictors of Disease-Free Survival in CD (1) Prostatic Cancer Patients Submitted to Radical Retropubic …
F Di Silverio, G D'Eramo, M Buscarini, A Sciarra, P Casale, S Di Nicola, ...
European urology 30 (3), 316-321, 1996
241996
Laparoscopic transperitoneal right adrenalectomy for ‘large’tumors
R Papalia, G Simone, C Leonardo, A Loreto, R Coppola, S Guaglianone, ...
Urologia Internationalis 81 (4), 437-440, 2008
202008
The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila
AL Rosell, M Paglione, J Gilley, M Kocia, G Perillo, M Gasparrini, ...
Elife 11, e80245, 2022
172022
系统目前无法执行此操作,请稍后再试。
文章 1–20